Inhibition of tumor angiogenesis by TTF1 from extract of herbal medicine
Inhibition of tumor angiogenesis by TTF1 from extract of herbal medicine
复制标题
草药提取物中 TTF1 对肿瘤血管生成的抑制作用
DOI:
10.3748/wjg.v17.i44.4875
复制
发表时间:
2011-11-28
影响因子:
4.3
通讯作者:
Zhang, Xue-Wu
中科院分区:
文献类型:
--
作者:
Liu, Chao;Li, Xiao-Wan;Zhang, Xue-Wu
AIM: To study the inhibition of tumor angiogenesis by 5,2,4'-trihydroxy-6,7,5'-trimethoxyflavone (TTF1) isolated from an extract of herbal medicine Sorbaria sorbifolia.METHODS: Angiogenic activity was assayed using the chick embryo chorioallantoic membrane (CAM) method. Microvessel density (MVD) was determined by staining tissue sections immunohistochemically for CD34 using the Weidner capillary counting method. The mRNA and protein levels of vascular endothelial growth factor (VEGF), vascular endothelialgrowth factor receptor 2 (VEGFR2, Flk-1/KDR), basic fibroblast growth factor (bFGF), cyclo-oxygenase (COX)-2 and hypoxia-inducible factor (HIF)-1 alpha were detected by quantitative real-time polymerase chain reaction and Western blotting analysis.RESULTS: The TTF1 inhibition rates for CAM were 30.8%, 38.2% and 47.5% with treatment concentrations of 25, 50 and 100 mu g/embryo x 5 d, respectively. The inhibitory rates for tumor size were 43.8%, 49.4% and 59.6% at TTF1 treatment concentrations of 5, 10, and 20 mu mol/kg, respectively. The average MVD was 14.2, 11.2 and 8.5 at treatment concentrations of 5 mu mol/kg, 10 mu mol/kg and 20 mu mol/kg TTF1, respectively. The mRNA and protein levels of VEGF, KDR, bFGF, COX-2 and HIF-1 alpha in mice treated with TTF1 were significantly decreased.CONCLUSION: TTF1 can inhibit tumor angiogenesis, and the mechanism may be associated with the down-regulation of VEGF, KDR, bFGF, HIF-1 alpha and COX-2. (C) 2011 Baishideng. All rights reserved.